Paul Cinciripini
Overview
Explore the profile of Paul Cinciripini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
727
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Cambron C, Hopkins P, Burningham C, Lam C, Cinciripini P, Wetter D
Drug Alcohol Depend
. 2020 Feb;
209:107840.
PMID: 32058242
Background: Models of health disparities highlight stress among low socioeconomic status (SES) smokers as a barrier to cessation. Recent studies suggest that mindfulness may improve cessation outcomes by reducing stress...
12.
Cambron C, Lam C, Cinciripini P, Li L, Wetter D
Ann Behav Med
. 2019 Oct;
54(3):141-150.
PMID: 31612218
Background: Low socioeconomic status (SES) is linked to failure to quit smoking. Health inequity models suggest that low SES smokers experience barriers to quitting in part due to greater exposure...
13.
Chido-Amajuoyi O, Mantey D, Cunningham S, Yu R, Kelder S, Hawk E, et al.
Addict Behav
. 2019 Oct;
100:106123.
PMID: 31605837
Background: Use of e-cigarettes for tobacco cessation efforts is a growing trend in the United States. However, little is known about the factors that determine the use of e-cigarettes for...
14.
Cambron C, Haslam A, Baucom B, Lam C, Vinci C, Cinciripini P, et al.
Health Psychol
. 2019 Sep;
38(12):1049-1058.
PMID: 31556660
Objective: Most attempts at smoking cessation are unsuccessful, and stress is frequently characterized both as a momentary precipitant of smoking lapse and a predictor of subsequent changes in other key...
15.
Ashare R, Thompson M, Leone F, Metzger D, Gross R, Mounzer K, et al.
AIDS
. 2019 Apr;
33(6):1083-1088.
PMID: 30946162
Objective: HIV-infected smokers lose more life years to tobacco use than to HIV infection. The nicotine metabolite ratio (NMR), a biomarker of CYP2A6, represents individual variation in the rate at...
16.
Cunningham S, Yu R, Shih T, Giordano S, McNeill L, Rechis R, et al.
Cancer Epidemiol Biomarkers Prev
. 2019 Feb;
28(3):486-494.
PMID: 30700446
Background: Cancer beliefs and perceptions of cancer risk affect the cancer continuum. Identifying underlying factors associated with these beliefs and perceptions in Texas can help inform and target prevention efforts....
17.
Peng A, Schnoll R, Hawk Jr L, Cinciripini P, George T, Lerman C, et al.
Drug Alcohol Depend
. 2018 Jul;
190:72-81.
PMID: 29986268
Introduction: Adherence to pharmacotherapies for tobacco dependence, such as varenicline, is necessary for effective treatment. The relationship between varenicline adherence, determined by commonly used indirect (i.e., self-reported pill counts) and...
18.
Peng A, Morales M, Wileyto E, Hawk Jr L, Cinciripini P, George T, et al.
Addict Behav
. 2017 Jul;
75:122-129.
PMID: 28728040
Introduction: While adherence to medication in smoking cessation clinical trials is strongly associated with clinical outcome, very few studies have evaluated the validity of pill count as a measure of...
19.
Ashare R, Lerman C, Tyndale R, Hawk L, George T, Cinciripini P, et al.
J Smok Cessat
. 2017 May;
12(2):63-70.
PMID: 28553407
Introduction: The nicotine-metabolite ratio (NMR) predicts treatment response and is related to treatment side effect severity. Sleep disturbance may be one important side effect, but understanding sleep disturbance effects on...
20.
Cinciripini P
J Natl Compr Canc Netw
. 2017 May;
15(5S):748-750.
PMID: 28515262
The harms of smoking cigarettes are well-known, and the benefits of smoking cessation are well-established. Smoking cessation is especially important for patients with cancer, because smoking compromises the effects of...